sec filing
CE
NASDAQ · CELU
Celularity Inc.
Healthcare · Biotechnology
$1.15
Up+$0.17 (+14.78%)
Updated Sep 24, 2026, 11:50 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 39.93M
- P/E ratio
- -0.54
- Dividend yield
- 0.00%
- 52-week range
- $0.56 – $2.55
- Volume
- 77.12K
- Avg. volume
- 124.95K
Price performance
CELU price history
1M range · 20 trading sessions · Daily adjusted prices
CELU closed at $1.15 after 20 trading sessions, up 30.62% for the selected period.
- Last close
- $1.15
- Period change
- +30.62%
- Period low
- $0.88
- Period high
- $2.10
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 23, 2026 | $1.17 | $1.18 | $1.13 | $1.15 | 77.12K |
| Sep 22, 2026 | $1.22 | $1.26 | $1.16 | $1.18 | 154.73K |
| Sep 21, 2026 | $1.27 | $1.33 | $1.24 | $1.24 | 214.04K |
| Sep 18, 2026 | $1.28 | $1.35 | $1.22 | $1.31 | 188.4K |
| Sep 17, 2026 | $1.29 | $1.38 | $1.27 | $1.27 | 77.76K |
| Sep 16, 2026 | $1.26 | $1.3891 | $1.21 | $1.29 | 181.1K |
| Sep 15, 2026 | $1.33 | $1.40 | $1.24 | $1.24 | 149.41K |
| Sep 14, 2026 | $1.32 | $1.43 | $1.31 | $1.40 | 206.97K |
| Sep 11, 2026 | $1.45 | $1.45 | $1.351 | $1.41 | 97.11K |
| Sep 10, 2026 | $1.405 | $1.48 | $1.3848 | $1.435 | 158.55K |
| Sep 9, 2026 | $1.55 | $1.55 | $1.43 | $1.44 | 148.75K |
| Sep 8, 2026 | $1.70 | $1.734 | $1.52 | $1.54 | 249.67K |
| Sep 4, 2026 | $1.83 | $1.83 | $1.6177 | $1.68 | 351.36K |
| Sep 3, 2026 | $1.85 | $1.8936 | $1.78 | $1.83 | 363.7K |
| Sep 2, 2026 | $1.88 | $1.96 | $1.69 | $1.86 | 654.74K |
| Sep 1, 2026 | $1.86 | $2.07 | $1.7101 | $1.88 | 1.62M |
| Aug 31, 2026 | $1.42 | $1.9643 | $1.38 | $1.85 | 3.42M |
| Aug 28, 2026 | $2.145 | $2.20 | $1.48 | $1.58 | 15.09M |
| Aug 27, 2026 | $1.11 | $2.55 | $0.926 | $2.10 | 221.05M |
| Aug 26, 2026 | $0.8058 | $0.9757 | $0.78 | $0.8804 | 177.41K |
Latest CELU news
The latest Smart Investors Daily articles mentioning CELU.
Stock researchResearch & News · SEC Filings
Loading stock research…